Skip to content

Learn More

We are a world-leading biotechnology investment firm
with three decades of experience creating and investing in innovative biotechnology companies
seeking to deliver transformative therapies to patients
in the areas of highest unmet medical need.

At our core, we are company creators. Our dedicated team of Entrepreneurs provide deep domain expertise in research and development, intellectual property, clinical strategy and commercialization – elements that we believe are crucial for successful company building.

MPM BioImpact manages early-stage venture funds, private/public impact funds and a public equities fund.  We convert science into therapeutics to reach the patients that need them most.

Learn more about our affiliate, BioImpact Capital